AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 283: R281-R283, 2002; doi:10.1152/ajpregu.00279.2002
0363-6119/02 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Vol. 283, Issue 2, R281-R283, August 2002

GUIDING PRINCIPLES
Guiding principles for research involving animals and human beings


    INTRODUCTION
TOP
INTRODUCTION
WORLD MEDICAL ASSOCIATION...
APS GUIDING PRINCIPLES IN...

THE AMERICAN PHYSIOLOGICAL SOCIETY (APS) endorses the Recommendations from the Declaration of Helsinki and the Guiding Principles in the Care and Use of Animals and insists that all investigations involving humans and all animal experimentation reported in its publications be conducted in conformity with these principles. Editors/Associate Editors are expected to refuse papers in which evidence of the adherence to these principles is not apparent. They reserve the right to judge the appropriateness of the use of animals and humans in experiments published in the journals. Differences of opinion will be adjudicated by the Publications Committee.


    WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI
TOP
INTRODUCTION
WORLD MEDICAL ASSOCIATION...
APS GUIDING PRINCIPLES IN...

Ethical Principles for Medical Research Involving Human Subjects1

A: Introduction.
 1) The World Medical Association has developed the Declaration of Helsinki as a statement of ethical principles to provide guidance to physicians and other participants in medical research involving human subjects. Medical research involving human subjects includes research on identifiable human material or identifiable data.

2) It is the duty of the physician to promote and safeguard the health of the people. The physician's knowledge and conscience are dedicated to the fulfillment of this duty.

3) The Declaration of Geneva of the World Medical Association binds the physician with the words, "The health of my patient will be my first consideration," and the International Code of Medical Ethics declares that, "A physician shall act only in the patient's interest when providing medical care which might have the effect of weakening the physical and mental condition of the patient."

4) Medical progress is based on research which ultimately must rest in part on experimentation involving human subjects.

5) In medical research on human subjects, considerations related to the well-being of the human subject should take precedence over the interests of science and society.

6) The primary purpose of medical research involving human subjects is to improve prophylactic, diagnostic and therapeutic procedures and the understanding of the aetiology and pathogenesis of disease. Even the best proven prophylactic, diagnostic, and therapeutic methods must continuously be challenged through research for their effectiveness, efficiency, accessibility and quality.

7) In current medical practice and in medical research, most prophylactic, diagnostic and therapeutic procedures involve risks and burdens.

8) Medical research is subject to ethical standards that promote respect for all human beings and protect their health and rights. Some research populations are vulnerable and need special protection. The particular needs of the economically and medically disadvantaged must be recognized. Special attention is also required for those who cannot give or refuse consent for themselves, for those who may be subject to giving consent under duress, for those who will not benefit personally from the research and for those for whom the research is combined with care.

9) Research Investigators should be aware of the ethical, legal and regulatory requirements for research on human subjects in their own countries as well as applicable international requirements. No national ethical, legal or regulatory requirement should be allowed to reduce or eliminate any of the protections for human subjects set forth in this Declaration.

B: Basic principles for all medical research.
 10) It is the duty of the physician in medical research to protect the life, health, privacy, and dignity of the human subject.

11) Medical research involving human subjects must conform to generally accepted scientific principles, be based on a thorough knowledge of the scientific literature, other relevant sources of information, and on adequate laboratory and, where appropriate, animal experimentation.

12) Appropriate caution must be exercised in the conduct of research which may affect the environment, and the welfare of animals used for research must be respected.

13) The design and performance of each experimental procedure involving human subjects should be clearly formulated in an experimental protocol. This protocol should be submitted for consideration, comment, guidance, and where appropriate, approval to a specially appointed ethical review committee, which must be independent of the investigator, the sponsor or any other kind of undue influence. This independent committee should be in conformity with the laws and regulations of the country in which the research experiment is performed. The committee has the right to monitor ongoing trials. The researcher has the obligation to provide monitoring information to the committee, especially any serious adverse events. The researcher should also submit to the committee, for review, information regarding funding, sponsors, institutional affiliations, other potential conflicts of interest and incentives for subjects.

14) The research protocol should always contain a statement of the ethical considerations involved and should indicate that there is compliance with the principles enunciated in this Declaration.

15) Medical research involving human subjects should be conducted only by scientifically qualified persons and under the supervision of a clinically competent medical person. The responsibility for the human subject must always rest with a medically qualified person and never rest on the subject of the research, even though the subject has given consent.

16) Every medical research project involving human subjects should be preceded by careful assessment of predictable risks and burdens in comparison with foreseeable benefits to the subject or to others. This does not preclude the participation of healthy volunteers in medical research. The design of all studies should be publicly available.

17) Physicians should abstain from engaging in research projects involving human subjects unless they are confident that the risks involved have been adequately assessed and can be satisfactorily managed. Physicians should cease any investigation if the risks are found to outweigh the potential benefits or if there is conclusive proof of positive and beneficial results.

18) Medical research involving human subjects should only be conducted if the importance of the objective outweighs the inherent risks and burdens to the subject. This is especially important when the human subjects are healthy volunteers.

19) Medical research is only justified if there is a reasonable likelihood that the populations in which the research is carried out stand to benefit from the results of the research.

20) The subjects must be volunteers and informed participants in the research project.

21) The right of research subjects to safeguard their integrity must always be respected. Every precaution should be taken to respect the privacy of the subject, the confidentiality of the patient's information and to minimize the impact of the study on the subject's physical and mental integrity and on the personality of the subject.

22) In any research on human beings, each potential subject must be adequately informed of the aims, methods, sources of funding, any possible conflicts of interest, institutional affiliations of the researcher, the anticipated benefits and potential risks of the study and the discomfort it may entail. The subject should be informed of the right to abstain from participation in the study or to withdraw consent to participate at any time without reprisal. After ensuring that the subject has understood the information, the physician should then obtain the subject's freely-given informed consent, preferably in writing. If the consent cannot be obtained in writing, the non-written consent must be formally documented and witnessed.

23) When obtaining informed consent for the research project the physician should be particularly cautious if the subject is in a dependent relationship with the physician or may consent under duress. In that case the informed consent should be obtained by a well-informed physician who is not engaged in the investigation and who is completely independent of this relationship.

24) For a research subject who is legally incompetent, physically or mentally incapable of giving consent or is a legally incompetent minor, the investigator must obtain informed consent from the legally authorized representative in accordance with applicable law. These groups should not be included in research unless the research is necessary to promote the health of the population represented and this research cannot instead be performed on legally competent persons.

25) When a subject deemed legally incompetent, such as a minor child, is able to give assent to decisions about participation in research, the investigator must obtain that assent in addition to the consent of the legally authorized representative.

26) Research on individuals from whom it is not possible to obtain consent, including proxy or advance consent, should be done only if the physical/mental condition that prevents obtaining informed consent is a necessary characteristic of the research population. The specific reasons for involving research subjects with a condition that renders them unable to give informed consent should be stated in the experimental protocol for consideration and approval of the review committee. The protocol should state that consent to remain in the research should be obtained as soon as possible from the individual or a legally authorized surrogate.

27) Both authors and publishers have ethical obligations. In publication of the results of research, the investigators are obliged to preserve the accuracy of the results. Negative as well as positive results should be published or otherwise publicly available. Sources of funding, institutional affiliations and any possible conflicts of interest should be declared in the publication. Reports of experimentation not in accordance with the principles laid down in this Declaration should not be accepted for publication.

C. Additional principles for medical research combined with medical care.
 28) The physician may combine medical research with medical care, only to the extent that the research is justified by its potential prophylactic, diagnostic or therapeutic value. When medical research is combined with medical care, additional standards apply to protect the patients who are research subjects.

29) The benefits, risks, burdens and effectiveness of a new method should be tested against those of the best current prophylactic, diagnostic, and therapeutic methods. This does not exclude the use of placebo, or no treatment, in studies where no proven prophylactic, diagnostic or therapeutic method exists. To further clarify the WMA position on the use of placebo-controlled trials, the WMA Council issued, during October 2001, the following note of clarification on article 29: The WMA is concerned that paragraph 29 of the revised Declaration of Helsinki (October 2000) has led to diverse interpretations and possible confusion. It hereby reaffirms its position that extreme care must be taken in making use of a placebo-controlled trial and that in general this methodology should only be used in the absence of existing proven therapy. However, a placebo-controlled trial may be ethically acceptable, even if proven therapy is available, under the following circumstances: Where for compelling and scientifically sound methodological reasons its use is necessary to determine the efficacy or safety of a prophylactic, diagnostic or therapeutic method; or Where a prophylactic, diagnostic or therapeutic method is being investigated for a minor condition and the patients who receive placebo will not be subject to any additional risk of serious or irreversible harm. All other provisions of the Declaration of Helsinki must be adhered to, especially the need for appropriate ethical and scientific review.

30) At the conclusion of the study, every patient entered into the study should be assured of access to the best proven prophylactic, diagnostic and therapeutic methods identified by the study.

31) The physician should fully inform the patient which aspects of the care are related to the research. The refusal of a patient to participate in a study must never interfere with the patient-physician relationship.

32) In the treatment of a patient, where proven prophylactic, diagnostic and therapeutic methods do not exist or have been ineffective, the physician, with informed consent from the patient, must be free to use unproven or new prophylactic, diagnostic and therapeutic measures, if in the physician's judgement it offers hope of saving life, re-establishing health or alleviating suffering. Where possible, these measures should be made the object of research, designed to evaluate their safety and efficacy. In all cases, new information should be recorded and, where appropriate, published. The other relevant guidelines of this Declaration should be followed.


    APS GUIDING PRINCIPLES IN THE CARE AND USE OF ANIMALS2
TOP
INTRODUCTION
WORLD MEDICAL ASSOCIATION...
APS GUIDING PRINCIPLES IN...

Animal experiments are to be undertaken only with the purpose of advancing knowledge. Consideration should be given to the appropriateness of experimental procedures, species of animals used, and number of animals required.

Only animals that are lawfully acquired shall be used in the laboratory, and their retention and use shall be in every case in compliance with federal, state and local laws and regulations, and in accordance with the Institute for Laboratory Animal Research (ILAR) Guide for Care and Use of Laboratory Animals.3

Animals used in research and education must receive every consideration for their comfort; they must be properly housed, fed, and their surroundings kept in a sanitary condition.

The use of animals must be in accordance with the ILAR Guide for Care and Use of Laboratory Animals. Appropriate anesthetics must be used to eliminate sensibility to pain during all surgical procedures. Drugs that produce muscle paralysis are not anesthetics, and they must not be used alone for surgical restraint, but may be used in conjunction with drugs known to produce adequate anesthesia. The care and use of animals shall be such as to minimize discomfort and pain. All measures to minimize pain and distress that would not compromise experimental results may be employed.

If the study requires the death of an animal, the most humane euthanasia method consistent with the study must be used.

When animals are used by students for their education or the advancement of science, such work shall be under the direct supervision of an experienced teacher or investigator.


    FOOTNOTES

1  Adopted by the 18th World Medical Association (WMA) General Assembly, Helsinki, Finland, June 1964, and amended by the 29th WMA General Assembly, Tokyo, Japan, October 1975; 35th WMA General Assembly, Venice, Italy, October 1983; 41st WMA General Assembly, Hong Kong, September 1989; 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996; and the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000.

See http://www.wma.net/e/policy/17-c_e.html.

2  Based on principles formulated in 1909 by Walter B. Cannon. APS Council first adopted the Guiding Principles in 1953. Latest revision approved July 2000.

3  Institute for Laboratory Animal Research. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996.

10.1152/ajpregu.00279.2002

Am J Physiol Regul Integr Comp Physiol 283(2):R281-R283


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Kurita, T. Nakada, A. Kato, H. Doi, A. C. Mistry, M.-H. Chang, M. F. Romero, and S. Hirose
Identification of intestinal bicarbonate transporters involved in formation of carbonate precipitates to stimulate water absorption in marine teleost fish
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1402 - R1412.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Kang, N. M. Sanders, A. A. Dunn-Meynell, L. D. Gaspers, V. H. Routh, A. P. Thomas, and B. E. Levin
Prior hypoglycemia enhances glucose responsiveness in some ventromedial hypothalamic glucosensing neurons
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R784 - R792.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Y. Yu, S.-G. Wei, Z.-H. Zhang, E. Gomez-Sanchez, R. M. Weiss, and R. B. Felder
Does Aldosterone Upregulate the Brain Renin-Angiotensin System in Rats With Heart Failure?
Hypertension, March 1, 2008; 51(3): 727 - 733.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. M. Patterson, A. A. Dunn-Meynell, and B. E. Levin
Three weeks of early-onset exercise prolongs obesity resistance in DIO rats after exercise cessation
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R290 - R301.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. L. Cham and E. Badoer
Hypothalamic paraventricular nucleus is critical for renal vasoconstriction elicited by elevations in body temperature
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F309 - F315.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-H. Zhang, Y. Yu, Y.-M. Kang, S.-G. Wei, and R. B. Felder
Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1067 - H1074.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
J. L. Cham and E. Badoer
Exposure to a hot environment can activate rostral ventrolateral medulla-projecting neurones in the hypothalamic paraventricular nucleus in conscious rats
Exp Physiol, January 1, 2008; 93(1): 64 - 74.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Kvochina, E. M. Hasser, and C. M. Heesch
Pregnancy increases baroreflex-independent GABAergic inhibition of the RVLM in rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2295 - R2305.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Nakada, K. Hoshijima, M. Esaki, S. Nagayoshi, K. Kawakami, and S. Hirose
Localization of ammonia transporter Rhcg1 in mitochondrion-rich cells of yolk sac, gill, and kidney of zebrafish and its ionic strength-dependent expression
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1743 - R1753.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Legendre, E. Papakonstantinou, M.-C. Roy, D. Richard, and R. B. S. Harris
Differences in response to corticotropin-releasing factor after short- and long-term consumption of a high-fat diet
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1076 - R1085.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Feleder, V. Perlik, and C. M. Blatteis
Preoptic norepinephrine mediates the febrile response of guinea pigs to lipopolysaccharide
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1135 - R1143.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
Y. Yu, Z.-H. Zhang, S.-G. Wei, Y. Chu, R. M. Weiss, D. D. Heistad, and R. B. Felder
Central Gene Transfer of Interleukin-10 Reduces Hypothalamic Inflammation and Evidence of Heart Failure in Rats After Myocardial Infarction
Circ. Res., August 3, 2007; 101(3): 304 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. A. O'Brien, V. Barnes, L. Zhao, R. A. McKnight, X. Yu, C. W. Callaway, L. Wang, J. C. Sun, M. J. Dahl, A. Wint, et al.
Uteroplacental insufficiency decreases p53 serine-15 phosphorylation in term IUGR rat lungs
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R314 - R322.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. B. S. Harris, T. D. Mitchell, E. W. Kelso, and W. P. Flatt
Changes in environmental temperature influence leptin responsiveness in low- and high-fat-fed mice
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R106 - R115.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
J. Zheng, B. Zhang, H. Bi, I. Maruko, I. Watanabe, C. Nakatsuka, E. L. Smith 3rd, and Y. M. Chino
Development of Temporal Response Properties and Contrast Sensitivity of V1 and V2 Neurons in Macaque Monkeys
J Neurophysiol, June 1, 2007; 97(6): 3905 - 3916.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. A. Herrera, V. M. Pulgar, R. A. Riquelme, E. M. Sanhueza, R. V. Reyes, G. Ebensperger, J. T. Parer, E. A. Valdez, D. A. Giussani, C. E. Blanco, et al.
High-altitude chronic hypoxia during gestation and after birth modifies cardiovascular responses in newborn sheep
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2234 - R2240.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. N. Gorski, A. A. Dunn-Meynell, and B. E. Levin
Maternal obesity increases hypothalamic leptin receptor expression and sensitivity in juvenile obesity-prone rats
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1782 - R1791.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Baserga, M. A. Hale, Z. M. Wang, X. Yu, C. W. Callaway, R. A. McKnight, and R. H. Lane
Uteroplacental insufficiency alters nephrogenesis and downregulates cyclooxygenase-2 expression in a model of IUGR with adult-onset hypertension
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1943 - R1955.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
J. L. Cham and E. Badoer
Cardiovascular Control: Exposure to a hot environment can activate spinally projecting and nitrergic neurones in the lower brainstem in the rat
Exp Physiol, May 1, 2007; 92(3): 529 - 540.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. G. Helwig, T. I. Musch, R. A. Craig, and M. J. Kenney
Increased interleukin-6 receptor expression in the paraventricular nucleus of rats with heart failure
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1165 - R1173.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G.-Q. Chang, O. Karatayev, R. Ahsan, V. Gaysinskaya, Z. Marwil, and S. F. Leibowitz
Dietary fat stimulates endogenous enkephalin and dynorphin in the paraventricular nucleus: role of circulating triglycerides
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E561 - E570.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Esaki, K. Hoshijima, S. Kobayashi, H. Fukuda, K. Kawakami, and S. Hirose
Visualization in zebrafish larvae of Na+ uptake in mitochondria-rich cells whose differentiation is dependent on foxi3a
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R470 - R480.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. E. Molina, H. Gesser, A. Llach, L. Tort, and L. Hove-Madsen
Modulation of membrane potential by an acetylcholine-activated potassium current in trout atrial myocytes
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R388 - R395.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. Southerland, D. M. Milhorn, R. D. Foreman, B. Linderoth, M. J. L. DeJongste, J. A. Armour, V. Subramanian, M. Singh, K. Singh, and J. L. Ardell
Preemptive, but not reactive, spinal cord stimulation mitigates transient ischemia-induced myocardial infarction via cardiac adrenergic neurons
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H311 - H317.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
S. C. Hempleman, S. X. Egan, J. Q. Pilarski, T. P. Adamson, and I. C. Solomon
Calcium and avian intrapulmonary chemoreceptor response to CO2
J Appl Physiol, December 1, 2006; 101(6): 1565 - 1575.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. M. Penn, L. C. Jordan, E. W. Kelso, J. E. Davenport, and R. B. S. Harris
Effects of central or peripheral leptin administration on norepinephrine turnover in defined fat depots
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1613 - R1621.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. W. Rajapakse, G. A. Eppel, R. E. Widdop, and R. G. Evans
ANG II type 2 receptors and neural control of intrarenal blood flow
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1669 - R1676.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Milutinovic, D. Murphy, and N. Japundzic-Zigon
The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1579 - R1591.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. R. Brown, L. A. Cassis, D. L. Silcox, L. V. Brown, and D. C. Randall
Empirical and theoretical analysis of the extremely low frequency arterial blood pressure power spectrum in unanesthetized rat
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2816 - H2824.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Cardinal, P. Page, M. Vermeulen, C. Bouchard, J. L. Ardell, R. D. Foreman, and J. A. Armour
Spinal cord stimulation suppresses bradycardias and atrial tachyarrhythmias induced by mediastinal nerve stimulation in dogs
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1369 - R1375.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Legendre and R. B. S. Harris
Exaggerated response to mild stress in rats fed high-fat diet
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1288 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. R. Noronha-de-Souza, K. C. Bicego, G. Michel, M. L. Glass, L. G. S. Branco, and L. H. Gargaglioni
Locus coeruleus is a central chemoreceptive site in toads
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R997 - R1006.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
Y.-M. Kang, Z.-H. Zhang, R. F. Johnson, Y. Yu, T. Beltz, A. K. Johnson, R. M. Weiss, and R. B. Felder
Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory Cytokines and Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure
Circ. Res., September 29, 2006; 99(7): 758 - 766.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. K. Ganta, B. G. Helwig, F. Blecha, R. R. Ganta, R. Cober, S. Parimi, T. I. Musch, R. J. Fels, and M. J. Kenney
Hypothermia-enhanced splenic cytokine gene expression is independent of the sympathetic nervous system
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R558 - R565.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. G. Helwig, S. Parimi, C. K. Ganta, R. Cober, R. J. Fels, and M. J. Kenney
Aging alters regulation of visceral sympathetic nerve responses to acute hypothermia
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R573 - R579.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. N. Gorski, A. A. Dunn-Meynell, T. G. Hartman, and B. E. Levin
Postnatal environment overrides genetic and prenatal factors influencing offspring obesity and insulin resistance
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R768 - R778.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
M. Waldmann, G. W. Thompson, G. C. Kember, J. L. Ardell, and J. A. Armour
Stochastic behavior of atrial and ventricular intrinsic cardiac neurons
J Appl Physiol, August 1, 2006; 101(2): 413 - 419.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Baserga, M. A. Hale, X. Ke, Z. M. Wang, X. Yu, C. W. Callaway, R. A. McKnight, and R. H. Lane
Uteroplacental insufficiency increases p53 phosphorylation without triggering the p53-MDM2 functional circuit response in the IUGR rat kidney
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R412 - R418.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. L. Barger, B. M. Barnes, and B. B. Boyer
Regulation of UCP1 and UCP3 in arctic ground squirrels and relation with mitochondrial proton leak
J Appl Physiol, July 1, 2006; 101(1): 339 - 347.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. L. Cham, R. Klein, N. C. Owens, M. Mathai, M. McKinley, and E. Badoer
Activation of spinally projecting and nitrergic neurons in the PVN following heat exposure
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R91 - R101.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Kantzides and E. Badoer
Activation of NADPH-diaphorase-positive projections to the rostral ventrolateral medulla following cardiac mechanoreceptor stimulation in the conscious rat
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1626 - R1638.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Wagoner, D. B. Hausman, and R. B. S. Harris
Direct and indirect effects of leptin on preadipocyte proliferation and differentiation
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1557 - R1564.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Z. Li, V. Perlik, C. Feleder, Y. Tang, and C. M. Blatteis
Kupffer cell-generated PGE2 triggers the febrile response of guinea pigs to intravenously injected LPS
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1262 - R1270.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
X. Ke, Q. Lei, S. J. James, S. L. Kelleher, S. Melnyk, S. Jernigan, X. Yu, L. Wang, C. W. Callaway, G. Gill, et al.
Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats
Physiol Genomics, March 13, 2006; 25(1): 16 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. F. Leibowitz, G.-Q. Chang, J. T. Dourmashkin, R. Yun, C. Julien, and P. P. Pamy
Leptin secretion after a high-fat meal in normal-weight rats: strong predictor of long-term body fat accrual on a high-fat diet
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E258 - E267.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. G. Krolikowski, M. Bienengraeber, D. Weihrauch, D. C. Warltier, J. R. Kersten, and P. S. Pagel
Inhibition of Mitochondrial Permeability Transition Enhances Isoflurane-Induced Cardioprotection During Early Reperfusion: The Role of Mitochondrial KATP Channels
Anesth. Analg., December 1, 2005; 101(6): 1590 - 1596.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Baserga, M. A. Hale, R. A. McKnight, X. Yu, C. W. Callaway, and R. H. Lane
Uteroplacental insufficiency alters hepatic expression, phosphorylation, and activity of the glucocorticoid receptor in fetal IUGR rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1348 - R1353.
[Abstract] [Full Text] [PDF]

Home page